Evaluation of ETC-1002 in Participants With Hypercholesterolemia and Hypertension

Clinical trial NCT02178098 · COMPLETED

Trial details

NCT number: NCT02178098
Sponsor: Esperion Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypercholesterolemia Hypertension

Start date: 2014-06-16
Primary completion: 2015-05-22
Enrollment: 143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.